Moderna Inc (MRNA)

353.60
+7.96(+2.30%)
Pre Market
361.00
+7.40(+2.09%)
- Real-time Data
  • Volume:
    11,345,689
  • Bid/Ask:
    361.00/361.50
  • Day's Range:
    342.28 - 359.90

MRNA Overview

Prev. Close
353.6
Day's Range
342.28-359.9
Revenue
2.73B
Open
346.9
52 wk Range
54.3-361.29
EPS
1.25
Volume
11,345,689
Market Cap
141.98B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
12,926,333
P/E Ratio
281.94
Beta
-
1-Year Change
377.19%
Shares Outstanding
401,527,789
Next Earnings Date
04 Aug 2021
What is your sentiment on Moderna Inc?
or
Market is currently closed. Voting is open during market hours.

Moderna Inc News

Moderna Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Buy
SummaryStrong SellSellStrong BuyStrong BuyStrong Buy

Moderna Inc Company Profile

Moderna Inc Company Profile

Employees
1300

Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.

Read More
  • moderna to be a 1000 dollar company soon .. probably in next 3 months..
    0
    • Hello, today the whole world is talking about the Moderna vaccine and the extension to other age groups
      0
      • Amazing
        0
        • I believe that we are at the beginning of a long journey: the quotation of Moderna today is related only to the Covid vaccine (Spikevax), as soon as the phases relating to the vaccine for CMV, HIV, CANCER and the others currently in progress are completed, it will not stop much easily . -Hello from the Moderna Italia forum-
          0
      • guys what are your thoughts in the market....
        0
        • sold some profits...amazing share wished i put more on them
          0
      • Is 320 possible?
        3
        • What was the question?
          0
        • 😢 Should I have sold, I hope not 😳
          0
        • hold
          0
      • this stock is scam like Tesla. Pfizer has more covid shots sold so why that one does not move that much
        7
        • Pfizer stock price had always behaved like a flaccid penis
          0
        • Pfizer has 5.5 billion outstanding shares whilst moderna has less than 500milliom hence price and fluctuations
          0
        • Check the prices of the vaccines...then u will get the bug picture.
          0
      • tgt 290
        0
        • Thanks🙌
          0
          • Sell side weak, support at 200, bullish. Same BNTX
            1
            • As always it will drop soon and drop again before earnings date.
              2
              • Bullish Bro
                0
                • Vote bullish thanks you
                  0
                  • Yes I think so too. MRNA have long time positive future.
                    1
                    • I was thinking it could be time to buy Moderna. Next Quater could have another positive surprise and Covid isn't going away just like that.
                      1
                      • My model predicts in 2022 a minimum price of 534 dollars per share. This is based on the forecasts of revenues of 2022, in a non favorable scenario. In a better scenario, Moderna could exceed 1000 dollars per share. The major asset of this company is the scalability and the ubiquitous use of digital technologies. Based on 2021 revenues forecast, each employee produces 4 millions in revenues. I could not find any other companies even close to this figure. I am glad people are wasting their money in crypto nonsense and tesla. Companies like moderna are estremely rare to find.
                        2
                    • With Germany, Switzerland, UK and Canada against the IP waiver, the WTO will never get the unanimity, so even if Biden avail it, nothing will happen and the Pharma companies including Moderna will rightfully protect their intellectual property. The booster line in phase 2 is very promising and Moderna has a futuristic view into drugs development investing heavily into AI
                      1
                      • The point is not the patent. The point is the manufacturing capability. It is too much to ask a policymaker to understand this argument.
                        1
                    • With Germany, Switzerland, UK and Canada against the IP waiver, the WTO will never get the unanimity, so even if Biden avail it, nothing will happen and the Pharma companies including Moderna will rightfully protect their intellectual property. The booster line in phase 2 is very promising and Moderna has a futuristic view into drugs development investing heavily into AI ....
                      1
                      • are the results out ?
                        0
                        • What happened
                          0
                          • What the heck is happening?
                            0
                            • Result not good ?
                              0
                            • But the same thing happend to pfizer and biontech!
                              0
                            • Vaccine patent waiver
                              0
                          • 300
                            0
                            • Paging for Oliver
                              0
                              • might get to 240 this week
                                2
                                • And it might get to 120
                                  1
                              • Good job MRNA. move forward. Bullish
                                1
                                • this will go through the roof tomorrow.
                                  0
                                  • moderna is likely to get approval in India soon..
                                    0
                                    • Might be approved but they can’t afford it. They produce AZ.
                                      0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.